Outsourced Pharma White Papers
-
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)
5/6/2026
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
Phase-Appropriate Approaches To Manufacturing And Testing
3/14/2025
Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.
-
Outsourcing Stability Storage: A Cost-Effective And Quality-Driven Approach
8/22/2024
Partnering with a leader in outsourced stability storage is revolutionizing the pharmaceutical and medical device industry by saving costs and resources, and ensuring product quality and compliance.
-
Mastering Modern Challenges In Drug Development Through Expert Technology Transfer
2/12/2026
Drawing on experience from hundreds of successful transfers, our experts recognize that informed decision-making at critical junctures can determine whether a program maintains momentum or loses it.
-
Untapped Potential In Animal Health Innovation
5/26/2026
Animal health innovation is driving rapid market growth, fueled by rising demand and complexity, creating opportunities for advanced therapies, sustainability, and better disease management.
-
Digital Innovation And Sustainability Are Redefining Biomanufacturing
12/8/2025
Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production.
-
The Role Of Extractables Data In The Adoption Of Single-Use Systems
8/29/2024
Explore guidance for evaluating single-use systems for extractables and leachables, and learn how supplier-provided single-use system extractables data can save both time and resources.
-
Advances In High-Concentration Protein Formulation Development
11/25/2025
High-concentration protein formulations improve patient convenience but face challenges like viscosity, aggregation, and surfactant degradation. Innovative strategies optimize stability, scalability, and quality for advanced biologics development.
-
Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer
3/24/2025
Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
Accelerating Drug Development: Solid State Chemistry And Strategic Outsourcing
5/6/2026
Discover how phase‑appropriate solid‑state chemistry and strategic outsourcing reduce risk, speed development timelines, and enable confident solid‑form selection for complex small‑molecule programs.